We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Univar's (UNVR) Earnings and Revenues Top Estimates in Q1
Read MoreHide Full Article
Univar Inc. logged a profit (on a reported basis) of $65.4 million or 46 cents per share in first-quarter 2018, rising almost three-fold from $22.6 million or 16 cents a year ago.
Barring one-time items, earnings came in at 42 cents per share in the quarter, surpassing the Zacks Consensus Estimate of 38 cents.
The chemical maker’s revenues rose 8% year over year to $2,158 million in the quarter, beating the Zacks Consensus Estimate of $2,137 million.
Gross profit rose around 10.7% year over year to $486.6 million in the quarter with gains witnessed across all segments. Adjusted EBITDA margin increased 70 basis points to 7.7%.
Revenues from the USA division increased 4.6% year over year to $1.2 billion in the reported quarter. Gross profit rose 6.1% year over year to $278.9 million.
Revenues from the Canada segment went up around 2% to $313.4 million. Gross profit rose roughly 11.8% to $62.4 million in the quarter.
The EMEA segment raked in sales of $538.6 million, up 22.5%. Gross profit rose around 21.8% to $124 million.
Sales from the Rest of World unit inched up 0.7% to $101.6 million. Gross profit grew 12.7% year over year to $21.3 million.
Balance Sheet
Univar ended the quarter with cash and cash equivalents of $115.9 million, down around 61.4% year over year. Long-term debt was $2,683.5 million, down around 7.6% year over year.
Outlook
For full-year 2018, Univar sees adjusted EBITDA growth of low-double digits. For 2018, adjusted earnings are expected in the range of $1.65-$1.85 per share, up from the previous guidance of $1.60-$1.80.
The company expects strong core business performance in the second quarter of 2018. It expects high single digit growth in adjusted EBITDA for the second quarter.
Price Performance
Univar has underperformed the industry over the last six months. The company’s shares have lost 11.8% over this period compared with the industry’s 3.1% decline.
FMC Corp has an expected long-term earnings growth rate of 13.6%. Its shares have gained around 20.2% over a year.
Huntsman has an expected long-term earnings growth rate of 8.3%. Its shares have moved up around 22.5% over a year.
Celanese has an expected long-term earnings growth rate of 8.9%. Its shares have gained around 28.5% over a year.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Univar's (UNVR) Earnings and Revenues Top Estimates in Q1
Univar Inc. logged a profit (on a reported basis) of $65.4 million or 46 cents per share in first-quarter 2018, rising almost three-fold from $22.6 million or 16 cents a year ago.
Barring one-time items, earnings came in at 42 cents per share in the quarter, surpassing the Zacks Consensus Estimate of 38 cents.
The chemical maker’s revenues rose 8% year over year to $2,158 million in the quarter, beating the Zacks Consensus Estimate of $2,137 million.
Gross profit rose around 10.7% year over year to $486.6 million in the quarter with gains witnessed across all segments. Adjusted EBITDA margin increased 70 basis points to 7.7%.
Univar Inc. Price, Consensus and EPS Surprise
Univar Inc. Price, Consensus and EPS Surprise | Univar Inc. Quote
Segment Review
Revenues from the USA division increased 4.6% year over year to $1.2 billion in the reported quarter. Gross profit rose 6.1% year over year to $278.9 million.
Revenues from the Canada segment went up around 2% to $313.4 million. Gross profit rose roughly 11.8% to $62.4 million in the quarter.
The EMEA segment raked in sales of $538.6 million, up 22.5%. Gross profit rose around 21.8% to $124 million.
Sales from the Rest of World unit inched up 0.7% to $101.6 million. Gross profit grew 12.7% year over year to $21.3 million.
Balance Sheet
Univar ended the quarter with cash and cash equivalents of $115.9 million, down around 61.4% year over year. Long-term debt was $2,683.5 million, down around 7.6% year over year.
Outlook
For full-year 2018, Univar sees adjusted EBITDA growth of low-double digits. For 2018, adjusted earnings are expected in the range of $1.65-$1.85 per share, up from the previous guidance of $1.60-$1.80.
The company expects strong core business performance in the second quarter of 2018. It expects high single digit growth in adjusted EBITDA for the second quarter.
Price Performance
Univar has underperformed the industry over the last six months. The company’s shares have lost 11.8% over this period compared with the industry’s 3.1% decline.
Zacks Rank & Other Stocks to Consider
Univar carries a Zacks Rank #2 (Buy).
Some other top-ranked companies in the basic materials space worth considering are FMC Corporation (FMC - Free Report) , Huntsman Corporation (HUN - Free Report) and Celanese Corporation (CE - Free Report) . All three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FMC Corp has an expected long-term earnings growth rate of 13.6%. Its shares have gained around 20.2% over a year.
Huntsman has an expected long-term earnings growth rate of 8.3%. Its shares have moved up around 22.5% over a year.
Celanese has an expected long-term earnings growth rate of 8.9%. Its shares have gained around 28.5% over a year.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>